Phase 4
Completed N=76
Carbetocin Versus Oxytocin and Hemodynamic Effects
Effects of; Anesthesia, in Pregnancy
Source: ClinicalTrials.gov NCT00977769 ↗
Enrolled (actual)
76
Serious AEs
0.0%
Results posted
May 2014
Primary outcomePrimary: Cardiac Output — 96; 82; 43 percentage change in cardiac output
Summary
A randomized double-blind trial of oxytocin 5 u, carbetocin 100 µg and placebo with hemodynamic response as a primary outcome measure.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Cardiac Output |
96; 82; 43 | — |
| PRIMARY Arterial Blood Pressure |
26; 28; 16 | — |
| SECONDARY Bleeding |
579; 841; 853 | — |
Eligibility Criteria
Inclusion Criteria
- Healthy pregnant women for planned cesarean section
Exclusion Criteria
- Bleeding disorders
- Placenta disorders
Data sourced from ClinicalTrials.gov (NCT00977769). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.